Atlas Trials

A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Clinical trial NCT06386419 · COMPLETED

Trial details

NCT number
NCT06386419
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Primary HypercholesterolemiaMixed Dyslipidemia
Start date
2024-11-12
Primary completion
2026-01-13
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.